Product description
Endone oxycodone hydrochloride 5mg tablet blister pack
Batch Number: CW612
Expiry: Nov 2020
AUST R: 14945
Batch Number: CW612
Expiry: Nov 2020
AUST R: 14945
See a list of details to help identify the product.
Reason the product is recalled
A report has been received that a strip of 30mg Anamorph tablets may have been present in a box of 5mg Endone, post dispensing.
The hazards to consumers
Anamorph tablets are approximately four times the Endone equivalent dose, so there is the potential of serious health risks and overdose, if taken inadvertently.
What consumers should do
Consumers should visually inspect blister sheets to verify both blister strips contain Endone tablets. If a blister is identified with Anamorph printed on the back, do not use the tablets from that strip. Return strips of incorrect tablets to the chemist or pharmacy from which they were purchased.
Further information is available on the TGA website at: https://www.tga.gov.au/alert/endone-5-mg-tablets
For further information, contact Aspen Pharma by phone on 1300 659 646 or email at medical@aspenpharmacare.com.au
Further information is available on the TGA website at: https://www.tga.gov.au/alert/endone-5-mg-tablets
For further information, contact Aspen Pharma by phone on 1300 659 646 or email at medical@aspenpharmacare.com.au
Details to help identify the product.
Supplier running the recall
Who sold the product
Pharmacies and Chemists
Identifying numbers
Other identifying numbers
Batch Number CW612
Where the product was sold
Nationally
Responsible regulators
Regulators are established or appointed by government. They enforce regulations and rules.
Quote PRA number 2019/17727 when contacting a regulator about this recall.
Recall and remedy questions
Contact the Therapeutic Goods Administration if you have:
- a question about the remedy being offered to you by the business that is responsible for managing this recall, or
- concerns about the way the business is managing this recall.